← Leaderboards
Pedro L. Delgado
University Of Arizona
$1,621,655
Attributed
$1,621,655
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $223.9K · FY2005–14$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,621,655 · 8
By mechanism
R01$1,155,923 · 2
R21$403,704 · 1
M01$62,028 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Michael A Wells$4,688,753
- Thomas Paul Davis$16,406,885
- Francisco A Moreno$28,024,896
Others in their field
Top investigators on “Tryptophan”
- David H Munn · Medical College Of Georgia (Mcg)$13,673,099
- Stephen R. Sprang · Cornell University Ithaca$9,760,892
- Rima F Kaddurah-Daouk · Duke University$9,167,767
- Diane C Chugani · Wayne State University$8,543,980
- Joseph J Mann · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc$8,038,119
- Joseph A. Baur · University Of Pennsylvania$7,943,084
Research focus
TryptophanSerotoninHuman SubjectClinical ResearchBehavioral /Social Science Research TagLongitudinal Human StudyMental Disorder ChemotherapyAntidepressantsPlasmaMental DepressionPsychotherapyHuman Therapy EvaluationNeurotransmitter TransportMajor Depressive DisorderMonitorParoxetineCognitive Behavior TherapyDepressive SymptomsFutureDiagnosticDisease RemissionMonoamineBrainDesign
Grant awards (15)
Bupropion for Depression in ESRD Patients on Hemodialysis$179,846
R21 · FY2014 · DK · contact PI
Bupropion for Depression in ESRD Patients on Hemodialysis$116,701
R21 · FY2013 · DK · contact PI
Bupropion for Depression in ESRD Patients on Hemodialysis$107,157
R21 · FY2013 · DK · contact PI
TRYPTOPHAN DEPLETION: A PHENOTYPIC MARKER FOR DEPRESSION$1,360
M01 · FY2008 · RR · contact PI
TRYPTOPHAN DEPLETION: A PHENOTYPIC MARKER FOR DEPRESSION$11,636
M01 · FY2007 · RR · contact PI
TRYPTOPHAN DEPLETION: A PHENOTYPIC MARKER FOR DEPRESSION$19,049
M01 · FY2005 · RR
TRYPTOPHAN DEPLETION IN PATIENTS ON PAROXETINE OR COGNITIVE THERAPY$3,175
M01 · FY2005 · RR
Tryptophan depletion in patients on paroxetine or cognitive therapy$18,729
M01 · FY2004 · RR
Serotonin function and vulnerability to depression$7,712
M01 · FY2004 · RR
Tryptophan depletion: A phenotypic marker for depression$367
M01 · FY2004 · RR
MECHANISMS UNDERLYING ANTIDEPRESSANT ACTION$295,960
R01 · FY2001 · MH
SEROTONIN FUNCTION AND VULNERABILTY TO DEPRESSION$230,035
R01 · FY2001 · MH
MECHANISMS UNDERLYING ANTIDEPRESSANT ACTION$251,760
R01 · FY2000 · MH
SEROTONIN FUNCTION AND VULNERABILTY TO DEPRESSION$247,428
R01 · FY2000 · MH
MECHANISMS UNDERLYING ANTIDEPRESSANT ACTION$130,740
R01 · FY2000 · MH